Hepatoblastoma is a rare liver cancer that mainly affects infants and young children. Researchers confirmed that breast cancer gene GREB1 plays a major role in hepatoblastoma cell proliferation. By interfering with GREB1 protein production, tumor formation was inhibited in a mouse liver cancer model, suggesting this approach could be used to develop a targeted hepatoblastoma therapy.
Click here for original story, Breast cancer gene a potential target for childhood liver cancer treatment
Source: ScienceDaily